发明名称 |
USE OF CO-LOCALIZED ISLETS AND SERTOLI CELLS IN XENOGRAFT CELLULAR TRANSPLANTS |
摘要 |
The present invention describes a method of treating a disease that results from a deficiency of a biological factor which comprises administering to a mammal Sertoli cells and cells that produce the biological factor. In particular, the present invention describes a method of treating diabetes mellitus by transplanting pancreatic islet of Langerhans cells in conjunction with Sertoli cells to create an immunologically privileged site. A method of creating an immunologically privileged site and providing cell stimulatory factors in a mammal for transplants is further described by the present invention. A method of co-localizing islet cells with Sertoli cells and the use of the co-localized product for treating diabetes mellitus is further provided. The present invention further describes a method of creating systemic tolerance to foreign antigens. A method of enhancing the viability, maturation, proliferation of functional capacity of cells in tissue culture is further provided. A pharmaceutical composition comprising Sertoli cells and cells that produce a biological factor is also provided. |
申请公布号 |
WO9640178(A1) |
申请公布日期 |
1996.12.19 |
申请号 |
WO1996US09627 |
申请日期 |
1996.06.07 |
申请人 |
RESEARCH CORPORATION TECHNOLOGIES, INC. |
发明人 |
SELAWRY, HELENA, P. |
分类号 |
A61K35/12;A61K35/48;A61K38/00;A61K38/13;A61K48/00;C12N5/071 |
主分类号 |
A61K35/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|